Early experience with cerebrospinal fluid cell-free DNA molecular profiling in a neuro-oncology practice
Cerebrospinal fluid (CSF) cell-free DNA (cfDNA) is increasingly used as a liquid biopsy in neuro-oncology for diagnosing lesions of uncertain etiology, distinguishing progression from pseudoprogression, and ruling out leptomeningeal disease (LMD). We assessed our institution’s early experience with a new CSF cfDNA mole...